Engine Bio
CRISPR + ML diagnostics platform
- Type
- Company / Project
- Vertical / Group
- Healthcare
- AI Relation
- Core AI
- Public Funding
- $10M+
- Website
- enginebio.com
Positioning
Engine Bio is tracked as a company or project in the Healthcare vertical of Singapore's AI startup ecosystem. Its public positioning is: CRISPR + ML diagnostics platform.
Capital And Market Signals
- Public funding signal: $10M+.
AI Relation
The main product or value proposition is directly built on AI, ML, computer vision, LLMs, robotics intelligence, or closely related model-driven capabilities. It can be treated as a strict AI company or AI project.
Why It Matters
Engine Bio is a concrete signal for whether Singapore can turn policy, talent, and research inputs into commercially useful AI companies in the Healthcare vertical.
Signals To Track
- Whether the product moves from a single AI feature toward a repeatable platform or industry workflow.
- Whether customers are mainly local, regional across Southeast Asia, or global.
- Whether signals such as funding, revenue, open-source traction, or regulatory clearance keep strengthening.
Related Entities
Biofourmis
AI platform for remote patient monitoring
Qritive
AI digital pathology diagnostics
Bot MD
AI assistant for clinicians
Nanyang Biologics
AI drug discovery
ADVANCE.AI
AI-driven digital identity verification and risk management
Aspire
SME finance platform (AI-enabled)
Data Note
This entity profile was organized and its AI-relation label was checked on 2026-05-04. Aggregate ecosystem statistics such as startup count, funding share, and total VC raised use the public baseline as of 2026-02-17. Funding, valuation, and exit amounts follow public reporting or public datasets; different databases may use different definitions for the same company.